Pharmacia Somavert
Executive Summary
Pharmacia is "working closely with FDA to resolve outstanding issues required for approval of the NDA" for Somavert (pegvisomant) in response to a recent "approvable" letter. The growth hormone receptor antagonist for treatment of acromegaly has orphan drug designation